The partnership between The Oncology Institute and Massive Bio is expected to have a positive impact on TOI's stock price in the short term. The collaboration aims to revolutionize cancer care and research using AI technology, which could potentially boost TOI's market position and attract more investors. The non-exclusive nature of the partnership allows for further collaborations, but the alliance with Massive Bio is still significant and relevant to TOI's core business.